NAVIGATE was evaluated from 2009-2014 in a cluster randomized controlled trial (RAISE-ETP). The RAISE-ETP team developed a comprehensive and integrated treatment intervention that they expected to:

​

• Promote symptomatic recovery

• Minimize disability

• Maximize social, academic, and vocational functioning

• Be capable of being delivered in real world settings utilizing current funding mechanisms

 

They assessed the overall clinical impact and cost-effectiveness of the intervention as compared to currently prevailing treatment approaches.  They conducted the comparison in non-academic, real world community treatment settings.

 

​

Outcomes of the Study:

• Remained in treatment longer

• Increased improvement in quality of life and psychopathology

• Greater involvement in work and school

• Median duration of untreated psychosis was 74 weeks

 

Participants with duration of untreated psychosis of

<74 weeks had greater improvement in quality of life and

psychopathology compared with those with longer duration

of untreated psychosis.

 

​

​

 

Overall:

• NAVIGATE provided greater improvement in symptoms and significantly greater improvement in real-world functioning, including social functioning and engagement in educational and vocational training

• Readily implementable across a broad range of community-based mental health settings

• More cost-effective compared to standard community care, driven by the anticipated enhanced health benefits and improvements in quality of life

 

Please refer to the RAISE Study page for more information.